Skip to content

Clinical study on the analgesic effects of neurotropin

Randomized paralleled controlled study on the analgesic effects of neurotropin in different TCM syndromes

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10001155
Enrollment
Unknown
Registered
2010-12-27
Start date
2011-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation, cervical spondylosis, diabetic peripheral neuropathy, herpes zoster neuralgia

Interventions

1:Neurotropin pill, 4 pills per day (divided in two times), for 28 days
2:Yuanhu Zhitong Capsule, 6 capsules per day (divided in three times), for 28 days

Sponsors

Dong Zhi Men Hospital, Beijing University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. With the diagnosis of lumbar disc herniation, cervical spondylosis, diabetic peripheral neuropathy or herpes zoster neuralgia based on western medicine diagnostic criteria; 2. VAS score >=3; 3. Aged between 18 and 65 years old; 4. Sign the informed content forms.

Exclusion criteria

Exclusion criteria: 1. Patients that are treated with analgesics within one week before the study; 2. Comorbidities of other primary diseases of cardiovascular system, liver, kidney and hematological system; combined with psychic disorders; 3. Allergic constitution; 4. Serum transaminase > 1.5 times of normal range; 5. Patients that take part in other drug trials within tree months of the study; 6. Pregnant or breast-feeding women; 7. With alcoholic or drug abuse history; or other conditions that are not suitable for the trial, such as frequent change of work place that might influence the follow-ups.

Design outcomes

Primary

MeasureTime frame
Blood routine tests and urine routine tests;Renal function;Paresthesia (numbness, coldness);Hepatic function;Overall assessment;The onset time of analgesic effect, time needed for pain relief, and maintenance time of analgesic e;Pain alleviation degree: VAS;

Secondary

MeasureTime frame
TCM syndromes;ECG;Improvement;Vital signs;Sleep quality;adverse event;

Countries

China

Contacts

Public ContactLiangduo JIANG
liangduojiang@163.com+86 010 84013402

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026